IP Library Granted Patent US 9,439,787
Granted Patent B2
US 9,439,787 · App. 13/798,885 · Granted Sep 13, 2016

Method of coating a stent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,439,787
App. No.
13/798,885
Granted
Sep 13, 2016
Kind
B2
Abstract

A method of coating a stent is provided that minimizes damage to the coating. The stent is self-expanding and made of a superelastic material. The stent is initially cooled so that at least part of the structure of the stent transforms to a martensitic phase. The stent is then compressed, coated and loaded while the structure of the stent remains at least partially martensitic. After the stent is loaded into a tubular restraint, the loaded stent is allowed to warm to room temperature.

Claims (21)

1. A method of coating and loading a superelastic self-expanding stent, comprising:

cooling a stent below a martensite start temperature, said stent being self-expanding and being made of a superelastic nickel-titanium memory shape metal material having a martensitic phase and an austenitic phase; compressing said stent after said cooling step while said stent remains below an austenite finish temperature; coating said stent with a drug to form a drug-coated stent after said compressing step while said stent remains below said austenite finish temperature; loading said drug-coated stent in a compressed state within a tubular restraint after said coating step while said drug-coated stent remains below said austenite finish temperature; and warming said stent within said tubular restraint after said loading step.

2. The method according to claim 1 , wherein said stent remains below an austenite start temperature during said compressing, coating and loading steps.

3. The method according to claim 1 , wherein said stent is cooled below a martensite finish temperature during said cooling step.

4. The method according to claim 3 , wherein said stent remains below an austenite start temperature during said compressing, coating and loading steps.

5. The method according to claim 4 , wherein said stent remains below a martensite finish temperature during said compressing, coating and loading steps.

6. The method according to claim 5 , wherein said stent is cooled below about −40° C. during said cooling step and said stent remains below about −40° C. during said compressing, coating and loading steps.

7. The method according to claim 1 , wherein said cooling, compressing, coating and loading steps occur within an enclosed chamber, an ambient temperature within said enclosed chamber remaining below said martensite start temperature.

8. The method according to claim 1 , wherein said cooling, compressing, coating and loading steps occur within an enclosed chamber, an ambient temperature within said enclosed chamber remaining below a martensite finish temperature.

9. The method according to claim 8 , wherein said enclosed chamber comprises a single chamber with sealed glove openings, an operator thereby being able to access said stent within said enclosed chamber to compress, coat and load said stent.

10. The method according to claim 1 , wherein said coating is applied to an outer surface of said stent.

11. The method according to claim 1 , wherein said coating step comprises ultrasonic spray deposition.

12. The method according to claim 1 , wherein said stent is compressed onto a mandrel in a crimper during said compressing step, said mandrel and said stent are transferred to a coating station after said compressing step, and said stent is transferred from said mandrel into said tubular restraint after said coating step.

13. The method according to claim 1 , wherein said tubular restraint is a restraining sheath of a delivery system for said stent.

14. The method of claim 1 , wherein said drug is selected from the group consisting of an antiproliferative and an anticoagulant.

15. The method according to claim 1 , wherein said stent remains below an austenite start temperature during said compressing, coating and loading steps, and said coating is applied to an outer surface of said stent.

16. The method according to claim 15 , wherein said tubular restraint is a restraining sheath of a delivery system for said stent.

17. The method according to claim 16 , wherein said stent is cooled below a martensite finish temperature during said cooling step, and said stent remains below a martensite finish temperature during said compressing, coating and loading steps.

18. The method according to claim 17 , wherein said cooling, compressing, coating and loading steps occur within an enclosed chamber, an ambient temperature within said enclosed chamber remaining below a martensite finish temperature.

19. The method according to claim 18 , wherein said enclosed chamber comprises a single chamber with sealed glove openings, an operator thereby being able to access said stent within said enclosed chamber to compress, coat and load said stent.

20. The method according to claim 17 , wherein said cooling, compressing, coating and loading steps occur within an enclosed chamber, an ambient temperature within said enclosed chamber remaining below a martensite finish temperature, and said stent is compressed onto a mandrel in a crimper during said compressing step, said mandrel and said stent are transferred to a coating station after said compressing step, and said stent is transferred from said mandrel into said restraining sheath after said coating step.

Assignments (4)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR INCORRECTLY IDENTIFIED AS WILLIAM COOK EUROPE APS PREVIOUSLY RECORDED ON REEL 030088 FRAME 0323. ASSIGNOR(S) HEREBY CONFIRMS THE THE CORRECT ASSIGNOR IS COOK INCORPORATED. Recorded May 16, 2013
From: COOK INCORPORATED
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 030435/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2013
From: WILLIAM COOK EUROPE APS
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 030088/0323 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2013
From: MOORE, WILLIAM F.; RIDGLEY, NATHAN S.
To: COOK, INCORPORATED
Reel/Frame 030078/0855 →